Percutaneous cryoablation of lung tumors: Feasibility and safety

Masanori Inoue, Seishi Nakatsuka, Hideki Yashiro, Nobutake Ito, Yotaro Izumi, Yoshikane Yamauchi, Kohei Hashimoto, Keisuke Asakura, Norimasa Tsukada, Masafumi Kawamura, Hiroaki Nomori, Sachio Kuribayashi

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Purpose: To evaluate the safety and feasibility of cryoablation for lung tumors as well as the incidence of, and risk factors for, complications. Materials and Methods: This study included 193 cryoablation sessions for 396 lung tumors in 117 consecutive patients. Univariate and multivariate analyses were performed to assess risk factors for common complications. Changes in laboratory values were analyzed the day after cryoablation. Results: Pneumothorax, pleural effusion, and hemoptysis occurred after 119 (61.7%), 136 (70.5%), and 71 (36.8%) sessions, respectively. Phrenic nerve palsy, frostbite, and empyema occurred after one session each (0.52%). Proximal tumor implantation was observed in one of 471 punctures (0.20%). Of 119 sessions with pneumothorax, 21 (17.6%) required chest tube insertion and two (1.7%) required pleurodesis. Delayed and recurrent pneumothorax occurred in 15 of 193 sessions each (7.8%). A greater number of cryoprobes was a significant (P =.001) predictor of pneumothorax. Male sex (P =.047) and no history of ipsilateral surgery (P =.012) were predictors for the need for chest tube insertion, and no history of ipsilateral surgery (P =.021) was a predictor for delayed/recurrent pneumothorax. Greater number of cryoprobes (P =.001) and no history of ipsilateral surgery (P =.004) were predictors for pleural effusion. Greater number of cryoprobes (P <.001) and younger age (P =.034) were predictors for hemoptysis. Mean changes in white blood cell count, platelet count, hemoglobin level, and C-reactive protein level were 2,418/μL ± 2,260 (P <.001), -2.0 × 10 4/μL ± 3.2 (P <.001), -0.77 mg/dL ± 0.89 (P <.001), and 3.0 mg/dL ± 2.9 (P <.001), respectively. Conclusions: Percutaneous cryoablation could be performed minimally invasively with acceptable rates of complications.

Original languageEnglish
Pages (from-to)295-302
Number of pages8
JournalJournal of Vascular and Interventional Radiology
Volume23
Issue number3
DOIs
Publication statusPublished - 2012 Mar

Fingerprint

Cryosurgery
Pneumothorax
Safety
Lung
Chest Tubes
Hemoptysis
Pleural Effusion
Neoplasms
Hemoglobin C
Frostbite
Pleurodesis
Phrenic Nerve
Empyema
Platelet Count
Leukocyte Count
Punctures
Paralysis
C-Reactive Protein
Multivariate Analysis
Incidence

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Percutaneous cryoablation of lung tumors : Feasibility and safety. / Inoue, Masanori; Nakatsuka, Seishi; Yashiro, Hideki; Ito, Nobutake; Izumi, Yotaro; Yamauchi, Yoshikane; Hashimoto, Kohei; Asakura, Keisuke; Tsukada, Norimasa; Kawamura, Masafumi; Nomori, Hiroaki; Kuribayashi, Sachio.

In: Journal of Vascular and Interventional Radiology, Vol. 23, No. 3, 03.2012, p. 295-302.

Research output: Contribution to journalArticle

Inoue, M, Nakatsuka, S, Yashiro, H, Ito, N, Izumi, Y, Yamauchi, Y, Hashimoto, K, Asakura, K, Tsukada, N, Kawamura, M, Nomori, H & Kuribayashi, S 2012, 'Percutaneous cryoablation of lung tumors: Feasibility and safety', Journal of Vascular and Interventional Radiology, vol. 23, no. 3, pp. 295-302. https://doi.org/10.1016/j.jvir.2011.11.019
Inoue, Masanori ; Nakatsuka, Seishi ; Yashiro, Hideki ; Ito, Nobutake ; Izumi, Yotaro ; Yamauchi, Yoshikane ; Hashimoto, Kohei ; Asakura, Keisuke ; Tsukada, Norimasa ; Kawamura, Masafumi ; Nomori, Hiroaki ; Kuribayashi, Sachio. / Percutaneous cryoablation of lung tumors : Feasibility and safety. In: Journal of Vascular and Interventional Radiology. 2012 ; Vol. 23, No. 3. pp. 295-302.
@article{c1b50caa7c98482c942f2f2d666c9bed,
title = "Percutaneous cryoablation of lung tumors: Feasibility and safety",
abstract = "Purpose: To evaluate the safety and feasibility of cryoablation for lung tumors as well as the incidence of, and risk factors for, complications. Materials and Methods: This study included 193 cryoablation sessions for 396 lung tumors in 117 consecutive patients. Univariate and multivariate analyses were performed to assess risk factors for common complications. Changes in laboratory values were analyzed the day after cryoablation. Results: Pneumothorax, pleural effusion, and hemoptysis occurred after 119 (61.7{\%}), 136 (70.5{\%}), and 71 (36.8{\%}) sessions, respectively. Phrenic nerve palsy, frostbite, and empyema occurred after one session each (0.52{\%}). Proximal tumor implantation was observed in one of 471 punctures (0.20{\%}). Of 119 sessions with pneumothorax, 21 (17.6{\%}) required chest tube insertion and two (1.7{\%}) required pleurodesis. Delayed and recurrent pneumothorax occurred in 15 of 193 sessions each (7.8{\%}). A greater number of cryoprobes was a significant (P =.001) predictor of pneumothorax. Male sex (P =.047) and no history of ipsilateral surgery (P =.012) were predictors for the need for chest tube insertion, and no history of ipsilateral surgery (P =.021) was a predictor for delayed/recurrent pneumothorax. Greater number of cryoprobes (P =.001) and no history of ipsilateral surgery (P =.004) were predictors for pleural effusion. Greater number of cryoprobes (P <.001) and younger age (P =.034) were predictors for hemoptysis. Mean changes in white blood cell count, platelet count, hemoglobin level, and C-reactive protein level were 2,418/μL ± 2,260 (P <.001), -2.0 × 10 4/μL ± 3.2 (P <.001), -0.77 mg/dL ± 0.89 (P <.001), and 3.0 mg/dL ± 2.9 (P <.001), respectively. Conclusions: Percutaneous cryoablation could be performed minimally invasively with acceptable rates of complications.",
author = "Masanori Inoue and Seishi Nakatsuka and Hideki Yashiro and Nobutake Ito and Yotaro Izumi and Yoshikane Yamauchi and Kohei Hashimoto and Keisuke Asakura and Norimasa Tsukada and Masafumi Kawamura and Hiroaki Nomori and Sachio Kuribayashi",
year = "2012",
month = "3",
doi = "10.1016/j.jvir.2011.11.019",
language = "English",
volume = "23",
pages = "295--302",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Percutaneous cryoablation of lung tumors

T2 - Feasibility and safety

AU - Inoue, Masanori

AU - Nakatsuka, Seishi

AU - Yashiro, Hideki

AU - Ito, Nobutake

AU - Izumi, Yotaro

AU - Yamauchi, Yoshikane

AU - Hashimoto, Kohei

AU - Asakura, Keisuke

AU - Tsukada, Norimasa

AU - Kawamura, Masafumi

AU - Nomori, Hiroaki

AU - Kuribayashi, Sachio

PY - 2012/3

Y1 - 2012/3

N2 - Purpose: To evaluate the safety and feasibility of cryoablation for lung tumors as well as the incidence of, and risk factors for, complications. Materials and Methods: This study included 193 cryoablation sessions for 396 lung tumors in 117 consecutive patients. Univariate and multivariate analyses were performed to assess risk factors for common complications. Changes in laboratory values were analyzed the day after cryoablation. Results: Pneumothorax, pleural effusion, and hemoptysis occurred after 119 (61.7%), 136 (70.5%), and 71 (36.8%) sessions, respectively. Phrenic nerve palsy, frostbite, and empyema occurred after one session each (0.52%). Proximal tumor implantation was observed in one of 471 punctures (0.20%). Of 119 sessions with pneumothorax, 21 (17.6%) required chest tube insertion and two (1.7%) required pleurodesis. Delayed and recurrent pneumothorax occurred in 15 of 193 sessions each (7.8%). A greater number of cryoprobes was a significant (P =.001) predictor of pneumothorax. Male sex (P =.047) and no history of ipsilateral surgery (P =.012) were predictors for the need for chest tube insertion, and no history of ipsilateral surgery (P =.021) was a predictor for delayed/recurrent pneumothorax. Greater number of cryoprobes (P =.001) and no history of ipsilateral surgery (P =.004) were predictors for pleural effusion. Greater number of cryoprobes (P <.001) and younger age (P =.034) were predictors for hemoptysis. Mean changes in white blood cell count, platelet count, hemoglobin level, and C-reactive protein level were 2,418/μL ± 2,260 (P <.001), -2.0 × 10 4/μL ± 3.2 (P <.001), -0.77 mg/dL ± 0.89 (P <.001), and 3.0 mg/dL ± 2.9 (P <.001), respectively. Conclusions: Percutaneous cryoablation could be performed minimally invasively with acceptable rates of complications.

AB - Purpose: To evaluate the safety and feasibility of cryoablation for lung tumors as well as the incidence of, and risk factors for, complications. Materials and Methods: This study included 193 cryoablation sessions for 396 lung tumors in 117 consecutive patients. Univariate and multivariate analyses were performed to assess risk factors for common complications. Changes in laboratory values were analyzed the day after cryoablation. Results: Pneumothorax, pleural effusion, and hemoptysis occurred after 119 (61.7%), 136 (70.5%), and 71 (36.8%) sessions, respectively. Phrenic nerve palsy, frostbite, and empyema occurred after one session each (0.52%). Proximal tumor implantation was observed in one of 471 punctures (0.20%). Of 119 sessions with pneumothorax, 21 (17.6%) required chest tube insertion and two (1.7%) required pleurodesis. Delayed and recurrent pneumothorax occurred in 15 of 193 sessions each (7.8%). A greater number of cryoprobes was a significant (P =.001) predictor of pneumothorax. Male sex (P =.047) and no history of ipsilateral surgery (P =.012) were predictors for the need for chest tube insertion, and no history of ipsilateral surgery (P =.021) was a predictor for delayed/recurrent pneumothorax. Greater number of cryoprobes (P =.001) and no history of ipsilateral surgery (P =.004) were predictors for pleural effusion. Greater number of cryoprobes (P <.001) and younger age (P =.034) were predictors for hemoptysis. Mean changes in white blood cell count, platelet count, hemoglobin level, and C-reactive protein level were 2,418/μL ± 2,260 (P <.001), -2.0 × 10 4/μL ± 3.2 (P <.001), -0.77 mg/dL ± 0.89 (P <.001), and 3.0 mg/dL ± 2.9 (P <.001), respectively. Conclusions: Percutaneous cryoablation could be performed minimally invasively with acceptable rates of complications.

UR - http://www.scopus.com/inward/record.url?scp=84857564890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857564890&partnerID=8YFLogxK

U2 - 10.1016/j.jvir.2011.11.019

DO - 10.1016/j.jvir.2011.11.019

M3 - Article

C2 - 22265246

AN - SCOPUS:84857564890

VL - 23

SP - 295

EP - 302

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

SN - 1051-0443

IS - 3

ER -